Select Page

As a leading healthcare market research agency, AplusA has extensive experience researching diseases within hermatology and hemato-oncology.

Hemophilia management is evolving as several new therapies for the treatment of both Hemophilia A and Hemophilia B are being launched or studied in clinical trials. Capitalizing on our unique expertise in patient chart-based research, the results from each wave of this study are based on real world data and monitor the impact of the new treatments for Hemophilia management. The latest wave of this study was conducted in 2020.

Fill in the form to access an overview of our Hemophilia A&B syndicated study including:

  • Objectives
  • Benefits
  • Samples
  • Scope
  • Types of data collected
  • Dates of research waves

You can also download our new Hemophilia A&B eBook:

Mockup Ebook AplusA Hemophilia 2020 EN

Download the eBook now

More information about Hemophilia A&B syndicated study? Fill out the form below and we will be in touch shortly.